Main > ONCOLOGY (**) > Multiple Myeloma R/R *** > Treatment > USA. B. ElotuzuMAb (+) (++)

---

USA. B. ElotuzuMAb (+) (++)'s subsections
(*) EU Approval OK: 2016. 05.11. ++
(*) EU Approval OK: 2019. 08.27. +
(*) USA Approval OK: 2015. 11.30.++
(*) USA Approval OK: 2018. 11.06. +
++Lenalidomide+Dexamethasone>
+Pomalidomide+Dexamethasone>
Company
Company CoDevelopment
Patent>Assignee; Claims; No.; Etc.
Patent>Total USA No.: 9
Patent>UpDate: 2018. 11.20.
TradeMark
TradeMark Web-Site

USA. B. ElotuzuMAb (+) (++)'s products
This section has no products